Ability to pass cannabis through blood-brain barrier holds promise for developing disease treatments

5w
2m read
Summary

A variety of treatments could be advanced for diseases such as Parkinson’s, Alzheimer’s, epilepsy, brain cancer and chronic pain, the article suggests. Subscribe to the Cannabis Post newsletter for weekly insights into the industry, what insiders will be talking about and content from across the Postmedia Network. Researchers say weed users may need more anaesthesia during surgery and have more pain afterward Researchers at Toronto-based St. A new technology from Nextage Therapeutics Ltd. is being touted as allowing cannabis molecules to reach the brain directly, an advancement that could drive forward the development of treatments for people suffering from a host of diseases. The company claims that its technology “enables broad distribution and improved exposure levels of therapeutic proteins throughout the brain.”   Want to keep up to date on what’s happening in the world of cannabis?

Article Preview

A new technology from Nextage Therapeutics Ltd. is being touted as allowing cannabis molecules to reach the brain directly, an advancement that could drive forward the development of treatments for people suffering from a host of diseases.

Based on research conducted at the Technion-Israel Institute of Technology, the ability for weed molecules to cross the blood-brain barrier (BBB) could reduce the necessary dosage of medical marijuana and minimize side effects caused by treatments spreading to other organs, according to an article...

Read the full article @ The Growth Op